These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 19260235
21. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance]. Yang CL, Qiu YR, Zhou F, Feng PF. Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223 [Abstract] [Full Text] [Related]
22. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM. J Clin Oncol; 2009 Sep 10; 27(26):4293-9. PubMed ID: 19667278 [Abstract] [Full Text] [Related]
23. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients. Ilea M, Zdrenghea D, Bodisz G, Mălai A, Gheorghiu L, Predescu D, Beudean M, Ossian V, Gligor E, Vlad C, Pop D, Bogdan E, Roşu R. Rom J Intern Med; 2008 Sep 10; 46(1):63-8. PubMed ID: 19157272 [Abstract] [Full Text] [Related]
24. Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP. Knebel F, Schimke I, Diaz Ramirez I, Schattke S, Eddicks S, Borges AC, Baumann G. Int J Cardiol; 2009 May 15; 134(2):260-3. PubMed ID: 18384896 [Abstract] [Full Text] [Related]
26. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction. Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK. Diabetes Res Clin Pract; 2007 Sep 26; 77 Suppl 1():S238-42. PubMed ID: 17490778 [Abstract] [Full Text] [Related]
27. Correlation of NT-proBNP levels and cardiac iron concentration in patients with transfusion-dependent thalassemia major. Delaporta P, Kattamis A, Apostolakou F, Boiu S, Bartzeliotou A, Tsoukas E, Papassotiriou I. Blood Cells Mol Dis; 2013 Jan 26; 50(1):20-4. PubMed ID: 23017692 [Abstract] [Full Text] [Related]
28. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease]. Zhang SR, Zhang YH, Xu Q, Qiu HX, Chen Q. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun 26; 11(6):429-32. PubMed ID: 19558803 [Abstract] [Full Text] [Related]
29. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy. Dini FL, Fontanive P, Conti U, Andreini D, Cabani E, De Tommasi SM. Am Heart J; 2008 Jun 26; 155(6):1121-7. PubMed ID: 18513528 [Abstract] [Full Text] [Related]
30. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients. Choi SY, Lee JE, Jang EH, Kim MO, Baek H, Ki CS, Park SW, Kim DJ, Huh WS, Oh HY, Kim YG. Nephron Clin Pract; 2008 Jun 26; 110(2):c93-100. PubMed ID: 18815449 [Abstract] [Full Text] [Related]
31. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications? Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, Bettencourt P. Nephron Clin Pract; 2009 Jun 26; 111(3):c182-8. PubMed ID: 19194108 [Abstract] [Full Text] [Related]
32. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure. Zdrenghea D, Pop D, Ilea M, Bodisz G, Mălai A, Zdrenghea M. Rom J Intern Med; 2009 Jun 26; 47(1):35-40. PubMed ID: 19886067 [Abstract] [Full Text] [Related]
33. NT-proBNP is not elevated in patients with obstructive sleep apnoea. Hübner RH, El Mokhtari NE, Freitag S, Rausche T, Göder R, Tiroke A, Lins M, Simon R, Bewig B. Respir Med; 2008 Jan 26; 102(1):134-42. PubMed ID: 17892929 [Abstract] [Full Text] [Related]
34. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study. Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA. J Vet Cardiol; 2009 May 26; 11 Suppl 1():S81-6. PubMed ID: 19394913 [Abstract] [Full Text] [Related]
35. Introduction of an NT-proBNP assay to an acute admission unit--a 2-year audit. Murtagh G, Canniffe C, Mahgoub M, Blake L, McCarroll N, Crowley V, Bennett K, Silke B. Eur J Intern Med; 2009 Jan 26; 20(1):58-62. PubMed ID: 19237094 [Abstract] [Full Text] [Related]
36. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies. Arnaldo FJ, Anatoliotakis N, Palacio C, Nabert DR, Hsu SS. Heart Lung; 2009 Jan 26; 38(1):10-6. PubMed ID: 19150526 [Abstract] [Full Text] [Related]
38. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study. Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Thanapiboonpol P, Nakyen S, Udompunturak S. J Card Fail; 2008 Oct 26; 14(8):687-94. PubMed ID: 18926441 [Abstract] [Full Text] [Related]
39. Exercise training in advanced heart failure patients: discordance between improved exercise tolerance and unchanged NT-proBNP levels. Arad M, Adler Y, Koren-Morag N, Natanzon S, Sela BA, Ben Dov I, Shechter M, Schwammenthal E, Freimark D. Int J Cardiol; 2008 May 07; 126(1):114-9. PubMed ID: 17651845 [Abstract] [Full Text] [Related]
40. NT-proBNP concentrations indicate cardiac disease in pediatric patients. Geiger R, Hammerer-Lercher A, Url C, Schweigmann U, Puschendorf B, Sommer R, Stein JI, Mair J. Int J Cardiol; 2007 Dec 15; 123(1):63-5. PubMed ID: 17289184 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]